Insider buying
~$3M2.07M sh @ $1.45
Largest insider buy since 2021Traded Nov 21, 2025 · filed 3 days later
Since the trade −11.4% · S&P 500 +4.7% · to Nov 20
Bought within 5% of the 52-week low, RSI 44, 21% under its 200-day average, 18 points behind the S&P 500 over 3 months
A major shareholder of Inhibikase Therapeutics paid $3M out of pocket for Inhibikase Therapeutics shares. Shares held went up 19% with this purchase.